Evidence map›Paper›PMID 42642419›Full record

ArticleNature communications2026

Cryo-EM structures of biopsy-derived TTR fibrils in hereditary transthyretin amyloidosis.

Yuxin Zheng, Jiawei Liang, Zhenyu Li, Yixiao Liu, Xujun Chu, Shaochong Zhang, Wenjuan Wang, Jionglin Bao, Boyu Liu, Conghui Ma and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuxin Zheng *Department of Pathology of the First Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, China.ORCID http://orcid.org/0009-0005-1542-3422
Jiawei Liang *Department of Pathology of the First Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Zhenyu Li *Department of Neurology, Peking University First Hospital, Beijing, China.
Yixiao LiuDepartment of Pathology of the First Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Xujun ChuDepartment of Neurology, Peking University First Hospital, Beijing, China.
Shaochong ZhangShenzhen Eye Hospital, Shenzhen Eye Center, Southern Medical University, Shenzhen, China.ORCID http://orcid.org/0000-0002-2212-7139
Wenjuan WangThe First Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou, China.
Jionglin BaoThe First Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou, China.
Boyu LiuThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Conghui MaThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Guowei YinThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Jianwen DengDepartment of Neurology, Peking University First Hospital, Beijing, China.ORCID http://orcid.org/0000-0003-1206-1778
Wei ChiShenzhen Eye Hospital, Shenzhen Eye Center, Southern Medical University, Shenzhen, China. chiwei@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-7424-3879
Lingchao MengDepartment of Neurology, Peking University First Hospital, Beijing, China. lcmeng@bjmu.edu.cn.
Yang ShiDepartment of Pathology of the First Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, China. yshi22@zju.edu.cn.ORCID http://orcid.org/0000-0003-1579-7561

Funding

Chinese Academy of Medical Sciences (CAMS) 2023-PT310-01Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) 2024A1515011296Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2025YFC3409700, 2024YFC3406200National Natural Science Foundation of China (National Science Foundation of China) 82371415, 82230031, 32350018Peking University (PKU) 2024IR12Science and Technology Department of Zhejiang Province 2024SSYS0018
6 · The paper itself

Abstract

Hereditary transthyretin amyloidosis (ATTRv) is a fatal autosomal dominant disease characterized by systemic deposition of transthyretin (TTR) amyloid fibrils, leading to progressive neuropathy and cardiomyopathy. More than 130 pathogenic mutations in the TTR gene have been identified, but their roles in TTR fibril formation and disease pathogenesis remain unclear. Here, using cryo-electron microscopy (cryo-EM), we present nineteen high-resolution TTR fibril structures (1.9-3.4 Å) from gastrocnemius muscle biopsies and vitreous humor of ten living ATTRv patients carrying nine distinct heterozygous mutations. Deep-learning-based analysis of cryo-EM densities enables semi-quantitative assessment of mutant or wild-type dominance within fibrils. These compositional profiles, combined with their structures, suggest an association between disease onset and the TTR species (wild-type or mutant) that primarily initiates amyloid formation. This biopsy-based workflow broadens access to patient tissue for amyloid structural studies, enabling systematic investigation of heterogeneous hereditary amyloidoses and the role of mutations in amyloid formation.

Indexed as

AmyloidAmyloid Neuropathies, FamilialCryoelectron MicroscopyPrealbuminBiopsyFemaleHumansMaleMuscle, SkeletalMutationAmyloidPrealbuminTTR protein, human

Identifiers

PMID42642419
PMCPMC13507274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.